Products Liability News
ENTREMED SECURES 10 MILLION STRATEGIC FINANCING
January 23, 2012
ROCKVILLE, Md., Jan. 23, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD - News), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured ...
Full Story Below
